161 related articles for article (PubMed ID: 36995111)
1. Molecular dynamics and absolute binding free energy studies of piperine derivatives as potential inhibitors of SARS-CoV-2 main protease.
Amperayani KR; Varadhi G; Oruganti B; Parimi UD
J Biomol Struct Dyn; 2023; 41(23):13696-13706. PubMed ID: 36995111
[TBL] [Abstract][Full Text] [Related]
2. Some Flavolignans as Potent Sars-Cov-2 Inhibitors
Cetin A
Curr Comput Aided Drug Des; 2022; 18(5):337-346. PubMed ID: 35975852
[TBL] [Abstract][Full Text] [Related]
3. Identification of a potential SARS-CoV2 inhibitor via molecular dynamics simulations and amino acid decomposition analysis.
Razzaghi-Asl N; Ebadi A; Shahabipour S; Gholamin D
J Biomol Struct Dyn; 2021 Oct; 39(17):6633-6648. PubMed ID: 32705953
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and molecular dynamics simulation studies of quinoline derivatives as protease inhibitors against SARS-CoV-2.
Singh VK; Chaurasia H; Kumari P; Som A; Mishra R; Srivastava R; Naaz F; Singh A; Singh RK
J Biomol Struct Dyn; 2022; 40(21):10519-10542. PubMed ID: 34253149
[TBL] [Abstract][Full Text] [Related]
5. Identification of natural inhibitors against Mpro of SARS-CoV-2 by molecular docking, molecular dynamics simulation, and MM/PBSA methods.
Sharma P; Joshi T; Mathpal S; Joshi T; Pundir H; Chandra S; Tamta S
J Biomol Struct Dyn; 2022 Apr; 40(6):2757-2768. PubMed ID: 33143552
[TBL] [Abstract][Full Text] [Related]
6.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
7. Pea eggplant (
Govender N; Zulkifli NS; Badrul Hisham NF; Ab Ghani NS; Mohamed-Hussein ZA
PeerJ; 2022; 10():e14168. PubMed ID: 36518265
[TBL] [Abstract][Full Text] [Related]
8. Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg
Al-Shuaeeb RAA; Abd El-Mageed HR; Ahmed SA; Mohamed HS; Hamza ZS; Rafi MO; Rahman MS
J Biomol Struct Dyn; 2023; 41(21):11437-11449. PubMed ID: 36591698
[TBL] [Abstract][Full Text] [Related]
9. Identification of alkaloids from
Ghosh R; Chakraborty A; Biswas A; Chowdhuri S
J Mol Struct; 2021 Apr; 1229():129489. PubMed ID: 33100380
[TBL] [Abstract][Full Text] [Related]
10. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2.
Islam R; Parves MR; Paul AS; Uddin N; Rahman MS; Mamun AA; Hossain MN; Ali MA; Halim MA
J Biomol Struct Dyn; 2021 Jun; 39(9):3213-3224. PubMed ID: 32340562
[TBL] [Abstract][Full Text] [Related]
11. Unraveling bioactive metabolites of mangroves as putative inhibitors of SARS-CoV-2 Mpro and RBD proteins: molecular dynamics and ADMET analysis.
Ramasubburayan R; Amperayani KR; Varadhi G; Dhanraj G; Athista M; Mahapatra S; Prakash S
J Biomol Struct Dyn; 2023 Oct; ():1-10. PubMed ID: 37897196
[TBL] [Abstract][Full Text] [Related]
12. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
13. Isatin-based virtual high throughput screening, molecular docking, DFT, QM/MM, MD and MM-PBSA study of novel inhibitors of SARS-CoV-2 main protease.
Varadharajan V; Arumugam GS; Shanmugam S
J Biomol Struct Dyn; 2022 Oct; 40(17):7852-7867. PubMed ID: 33764269
[TBL] [Abstract][Full Text] [Related]
14. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study.
Ancy I; Sivanandam M; Kumaradhas P
J Biomol Struct Dyn; 2021 Sep; 39(15):5368-5375. PubMed ID: 32627689
[TBL] [Abstract][Full Text] [Related]
15. Virtual screening of natural products inspired in-house library to discover potential lead molecules against the SARS-CoV-2 main protease.
Garg A; Goel N; Abhinav N; Varma T; Achari A; Bhattacharjee P; Kamal IM; Chakrabarti S; Ravichandiran V; Reddy AM; Gupta S; Jaisankar P
J Biomol Struct Dyn; 2023 Mar; 41(5):2033-2045. PubMed ID: 35043750
[TBL] [Abstract][Full Text] [Related]
16. Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease.
Fadaka AO; Sibuyi NRS; Martin DR; Klein A; Madiehe A; Meyer M
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502340
[TBL] [Abstract][Full Text] [Related]
17. Identification of medicinal plant-based phytochemicals as a potential inhibitor for SARS-CoV-2 main protease (M
Hossain A; Rahman ME; Rahman MS; Nasirujjaman K; Matin MN; Faruqe MO; Rabbee MF
Comput Biol Med; 2023 May; 157():106785. PubMed ID: 36931201
[TBL] [Abstract][Full Text] [Related]
18. Unsymmetrical aromatic disulfides as SARS-CoV-2 Mpro inhibitors: Molecular docking, molecular dynamics, and ADME scoring investigations.
Chtita S; Belaidi S; Qais FA; Ouassaf M; AlMogren MM; Al-Zahrani AA; Bakhouch M; Belhassan A; Zaki H; Bouachrine M; Lakhlifi T
J King Saud Univ Sci; 2022 Oct; 34(7):102226. PubMed ID: 35875823
[TBL] [Abstract][Full Text] [Related]
19. Combined molecular docking and dynamics simulations studies of natural compounds as potent inhibitors against SARS-CoV-2 main protease.
Ouassaf M; Belaidi S; Chtita S; Lanez T; Abul Qais F; Md Amiruddin H
J Biomol Struct Dyn; 2022; 40(21):11264-11273. PubMed ID: 34315340
[TBL] [Abstract][Full Text] [Related]
20. An investigation for the interaction of gamma oryzanol with the Mpro of SARS-CoV-2 to combat COVID-19: DFT, molecular docking, ADME and molecular dynamics simulations.
Raman APS; Singh MB; Vishvakarma VK; Jain P; Kumar A; Sachdeva S; Kumari K; Singh P
J Biomol Struct Dyn; 2023 Mar; 41(5):1919-1929. PubMed ID: 35067190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
